Serum selenium and its therapeutic effects on serum biomarkers in hemodialysis patients
Not Applicable
- Conditions
- hemodialysis patients.End-stage renal disease
- Registration Number
- IRCT2013081414333N2
- Lead Sponsor
- Vice Chancellor for Research Affairs, Kermanshah University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
the patient's willingness to cooperate; at least 6 months passing after dialysis starting . Exclusion criteria: hepatitis; other infectious diseases; steroidal and non-steroidal anti-inflammatory drugs or vitamins E,C usage within two months before the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Selenium. Timepoint: day 0,90. Method of measurement: by cell counter.;Cholestrol. Timepoint: day 0 ,90. Method of measurement: by cell counter.;H.d.L. Timepoint: day 0,90. Method of measurement: by cell counter.;L.D.L. Timepoint: day 0,90. Method of measurement: by cell counter.;Serum. Timepoint: day 0,90. Method of measurement: by cell counter.;Triglycerides. Timepoint: day 0,90. Method of measurement: by cell counter.
- Secondary Outcome Measures
Name Time Method